Susquehanna International Group
PTCT icon

Susquehanna International Group’s PTC Therapeutics PTCT Stock Holding History

Susquehanna International Group’s Portfolio PTCT Stock Details PTCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.9M Sell
71,900
-57,300
-44% -$4.06M ﹤0.01% 4261
2025
Q4 		$9.81M Sell
129,200
-90,500
-41% -$6.58M ﹤0.01% 3063
2025
Q3 		$13.5M Buy
219,700
+77,000
+54% +$4.01M ﹤0.01% 2638
2025
Q2 		$6.97M Sell
142,700
-30,200
-17% -$1.43M ﹤0.01% 3381
2025
Q1 		$8.81M Buy
172,900
+41,700
+32% +$2.08M ﹤0.01% 2701
2024
Q4 		$5.92M Buy
131,200
+77,200
+143% +$3.3M ﹤0.01% 3351
2024
Q3 		$2M Sell
54,000
-29,200
-35% -$978K ﹤0.01% 5261
2024
Q2 		$2.54M Buy
83,200
+67,700
+437% +$2.19M ﹤0.01% 4615
2024
Q1 		$451K Sell
15,500
-21,100
-58% -$591K ﹤0.01% 8746
2023
Q4 		$1.01M Sell
36,600
-32,200
-47% -$736K ﹤0.01% 6975
2023
Q3 		$1.54M Sell
68,800
-31,300
-31% -$1.16M ﹤0.01% 5676
2023
Q2 		$4.07M Buy
100,100
+86,100
+615% +$4.21M ﹤0.01% 3863
2023
Q1 		$678K Sell
14,000
-43,800
-76% -$2M ﹤0.01% 7808
2022
Q4 		$2.21M Sell
57,800
-20,400
-26% -$848K ﹤0.01% 4518
2022
Q3 		$3.93M Buy
+78,200
New +$3.83M ﹤0.01% 3547
2022
Q2 		– Sell
-40,800
Closed -$1.52M – 13725
2022
Q1 		$1.52M Buy
40,800
+24,200
+146% +$932K ﹤0.01% 6099
2021
Q4 		$661K Sell
16,600
-62,200
-79% -$2.38M ﹤0.01% 8415
2021
Q3 		$2.93M Buy
78,800
+25,800
+49% +$1.06M ﹤0.01% 5006
2021
Q2 		$2.24M Sell
53,000
-66,500
-56% -$2.85M ﹤0.01% 5660
2021
Q1 		$5.66M Buy
119,500
+66,700
+126% +$3.96M ﹤0.01% 3671
2020
Q4 		$3.22M Sell
52,800
-80,600
-60% -$4.75M ﹤0.01% 4184
2020
Q3 		$6.24M Sell
133,400
-6,600
-5% -$325K ﹤0.01% 2781
2020
Q2 		$7.1M Buy
140,000
+29,000
+26% +$1.42M ﹤0.01% 2562
2020
Q1 		$4.95M Sell
111,000
-173,300
-61% -$8.73M ﹤0.01% 2589
2019
Q4 		$13.7M Sell
284,300
-64,400
-18% -$2.74M ﹤0.01% 1776
2019
Q3 		$11.8M Buy
348,700
+229,300
+192% +$9.98M ﹤0.01% 1800
2019
Q2 		$5.37M Sell
119,400
-22,800
-16% -$900K ﹤0.01% 2616
2019
Q1 		$5.35M Sell
142,200
-55,200
-28% -$1.85M ﹤0.01% 2365
2018
Q4 		$6.78M Sell
197,400
-12,200
-6% -$439K ﹤0.01% 1955
2018
Q3 		$9.85M Buy
209,600
+23,400
+13% +$968K ﹤0.01% 1955
2018
Q2 		$6.28M Sell
186,200
-24,900
-12% -$777K ﹤0.01% 2457
2018
Q1 		$5.71M Sell
211,100
-56,800
-21% -$1.44M ﹤0.01% 2386
2017
Q4 		$4.47M Sell
267,900
-273,900
-51% -$4.64M ﹤0.01% 2662
2017
Q3 		$10.8M Buy
541,800
+317,500
+142% +$6.22M ﹤0.01% 1705
2017
Q2 		$4.11M Sell
224,300
-74,800
-25% -$1.01M ﹤0.01% 2666
2017
Q1 		$2.94M Sell
299,100
-136,500
-31% -$1.65M ﹤0.01% 3063
2016
Q4 		$4.75M Buy
435,600
+219,900
+102% +$2.31M ﹤0.01% 2513
2016
Q3 		$3.02M Buy
215,700
+48,900
+29% +$398K ﹤0.01% 2891
2016
Q2 		$1.17M Sell
166,800
-133,000
-44% -$975K ﹤0.01% 4537
2016
Q1 		$1.93M Buy
299,800
+41,200
+16% +$715K ﹤0.01% 3845
2015
Q4 		$8.38M Sell
258,600
-108,000
-29% -$3.18M ﹤0.01% 1932
2015
Q3 		$9.79M Buy
366,600
+161,400
+79% +$6.9M ﹤0.01% 1850
2015
Q2 		$9.88M Buy
205,200
+73,800
+56% +$4.31M ﹤0.01% 2016
2015
Q1 		$8M Buy
131,400
+127,500
+3,269% +$7.78M ﹤0.01% 2121
2014
Q4 		$202K Buy
+3,900
New +$172K ﹤0.01% 8800

Other funds holding PTCT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Susquehanna International Group's PTCT Position: Q1 2026 in Review

Susquehanna International Group increased its PTC Therapeutics (PTCT) stake by 1,013% in Q1 2026, buying an estimated $13.4M and bringing the position to 207,938 shares worth $14.2M. The position accounts for ﹤0.01% of the portfolio, ranked #2633.

Susquehanna International Group first reported a position in PTCT in Q1 2014 and has held it in 40 quarters since. The position peaked at $21.1M in Q2 2025. 351 funds tracked by Wall St. Rank hold PTCT as of Q1 2026.

  • Susquehanna International Group held 207,938 shares of PTC Therapeutics worth $14.2M as of Q1 2026.
  • Susquehanna International Group bought 189,257 PTC Therapeutics shares in Q1 2026, an estimated $13.4M.
  • PTC Therapeutics made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #2633 holding.
  • Susquehanna International Group first reported a position in PTC Therapeutics in Q1 2014 and has held it in 40 quarters since.
  • Susquehanna International Group's PTC Therapeutics position peaked at $21.1M in Q2 2025.
  • 351 funds tracked by Wall St. Rank held PTC Therapeutics as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.